Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Top Cited Papers
Open Access
- 9 April 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 586
Abstract
Cytokine dysregulation is believed to play a key role in the remodeling of the immune system at older age, with evidence pointing to an inability to fine-control systemic inflammation, which seems to be a marker of unsuccessful aging. This reshaping of cytokine expression pattern, with a progressive tendency toward a pro-inflammatory phenotype has been called “inflamm-aging.” Despite research there is no clear understanding about the causes of “inflamm-aging” that underpin most major age-related diseases, including atherosclerosis, diabetes, Alzheimer’s disease, rheumatoid arthritis, cancer, and aging itself. While inflammation is part of the normal repair response for healing, and essential in keeping us safe from bacterial and viral infections and noxious environmental agents, not all inflammation is good. When inflammation becomes prolonged and persists, it can become damaging and destructive. Several common molecular pathways have been identified that are associated with both aging and low-grade inflammation. The age-related change in redox balance, the increase in age-related senescent cells, the senescence-associated secretory phenotype (SASP) and the decline in effective autophagy that can trigger the inflammasome, suggest that it may be possible to delay age-related diseases and aging itself by suppressing pro-inflammatory molecular mechanisms or improving the timely resolution of inflammation. Conversely there may be learning from molecular or genetic pathways from long-lived cohorts who exemplify good quality aging. Here, we will discuss some of the current ideas and highlight molecular pathways that appear to contribute to the immune imbalance and the cytokine dysregulation, which is associated with “inflammageing” or parainflammation. Evidence of these findings will be drawn from research in cardiovascular disease, cancer, neurological inflammation and rheumatoid arthritis.Keywords
This publication has 447 references indexed in Scilit:
- Frailty in Old Age Is Associated with Decreased Interleukin-12/23 Production in Response to Toll-Like Receptor LigationPLOS ONE, 2013
- Slower immune system aging in women versus men in the Japanese populationImmunity & Ageing, 2013
- Tumour inflammasome‐derived IL‐1β recruits neutrophils and improves local recurrence‐free survival in EBV‐induced nasopharyngeal carcinomaEMBO Molecular Medicine, 2012
- Interleukin 18 and coronary heart disease: Prospective study and systematic reviewAtherosclerosis, 2011
- Immunity, Inflammation, and CancerCell, 2010
- Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibilityHuman Genetics, 2010
- Immunosenescence: what does it mean to health outcomes in older adults?Current Opinion in Immunology, 2009
- Senescence of Activated Stellate Cells Limits Liver FibrosisCell, 2008
- Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-agingAgeing Research Reviews, 2008
- Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) studyAtherosclerosis, 2008